SCREENING METHOD AND SCREENING REAGENT OF CANCER BY DETECTION OF EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN 2 CO-ACTIVATOR P100

摘要

PROBLEM TO BE SOLVED: To provide a diagnosis marker highly required for a diagnosis in a prostate cancer and specifically detecting only the malignant prostate cancer for requiring an active treatment without detecting the prostate cancer not requiring the active treatment as a latent cancer. SOLUTION: The invention provides a method for inspecting the cancer by detecting an Epstein-Barr virus nuclear antigen 2 Co-activator p100. COPYRIGHT: (C)2008,JPO&INPIT